Cargando…
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
Autores principales: | Alvarez-Gamero, Julio César, García-Ruiz, Victor Raúl, Paz-Ibarra, Jose Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991021/ https://www.ncbi.nlm.nih.gov/pubmed/35263055 http://dx.doi.org/10.20945/2359-3997000000453 |
Ejemplares similares
-
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
Publicado: (2022) -
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
por: Vicente, Nuno, et al.
Publicado: (2017) -
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes
por: Mizutani, Gen, et al.
Publicado: (2018) -
Fetal and Neonatal Goiter in Cynomolgus Monkeys Following Administration of the Antithyroid Drug Thiamazole at High Doses to Dams During Pregnancy
por: Yoshikawa, Tsuyoshi, et al.
Publicado: (2011)